T. Rowe Price Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-181,226
Closed -$4.33M 2977
2021
Q1
$4.33M Sell
181,226
-1,690,847
-90% -$40.4M ﹤0.01% 1495
2020
Q4
$27.3M Sell
1,872,073
-40,351
-2% -$589K ﹤0.01% 1133
2020
Q3
$27.2M Sell
1,912,424
-33,554
-2% -$476K ﹤0.01% 1069
2020
Q2
$28.6M Sell
1,945,978
-174,069
-8% -$2.56M ﹤0.01% 1032
2020
Q1
$8.74M Buy
2,120,047
+6,468
+0.3% +$26.6K ﹤0.01% 1254
2019
Q4
$10.2M Sell
2,113,579
-886,572
-30% -$4.26M ﹤0.01% 1309
2019
Q3
$18.2M Sell
3,000,151
-3,589,340
-54% -$21.8M ﹤0.01% 1181
2019
Q2
$42.8M Sell
6,589,491
-1,101,642
-14% -$7.15M 0.01% 938
2019
Q1
$54.5M Sell
7,691,133
-453,261
-6% -$3.21M 0.01% 836
2018
Q4
$39.6M Sell
8,144,394
-512,925
-6% -$2.49M 0.01% 907
2018
Q3
$63.6M Sell
8,657,319
-200,447
-2% -$1.47M 0.01% 821
2018
Q2
$56.5M Sell
8,857,766
-30,244
-0.3% -$193K 0.01% 843
2018
Q1
$48.4M Buy
8,888,010
+56,372
+0.6% +$307K 0.01% 888
2017
Q4
$36.8M Buy
8,831,638
+2,233,030
+34% +$9.31M 0.01% 981
2017
Q3
$63.5M Buy
6,598,608
+1,638,377
+33% +$15.8M 0.01% 762
2017
Q2
$58.7M Buy
4,960,231
+953,911
+24% +$11.3M 0.01% 773
2017
Q1
$51.4M Buy
4,006,320
+126,506
+3% +$1.62M 0.01% 797
2016
Q4
$47.5M Buy
3,879,814
+108,460
+3% +$1.33M 0.01% 826
2016
Q3
$44.5M Buy
3,771,354
+1,102,600
+41% +$13M 0.01% 849
2016
Q2
$23.2M Sell
2,668,754
-1,400
-0.1% -$12.2K ﹤0.01% 1050
2016
Q1
$14.1M Buy
2,670,154
+87,300
+3% +$460K ﹤0.01% 1184
2015
Q4
$20M Buy
2,582,854
+48,500
+2% +$376K ﹤0.01% 1083
2015
Q3
$19.9M Sell
2,534,354
-30,200
-1% -$238K ﹤0.01% 1088
2015
Q2
$23.2M Buy
2,564,554
+1,500
+0.1% +$13.6K ﹤0.01% 1084
2015
Q1
$33.3M Sell
2,563,054
-5,700
-0.2% -$74K 0.01% 973
2014
Q4
$35M Sell
2,568,754
-18,000
-0.7% -$245K 0.01% 964
2014
Q3
$23.2M Buy
2,586,754
+4,400
+0.2% +$39.5K 0.01% 1068
2014
Q2
$34.9M Sell
2,582,354
-77,546
-3% -$1.05M 0.01% 971
2014
Q1
$26.4M Buy
2,659,900
+4,800
+0.2% +$47.7K 0.01% 1039
2013
Q4
$35.3M Sell
2,655,100
-1,558,500
-37% -$20.7M 0.01% 942
2013
Q3
$51.2M Buy
4,213,600
+319,900
+8% +$3.89M 0.01% 807
2013
Q2
$40.3M Buy
+3,893,700
New +$40.3M 0.01% 850